Sensars

📍 West Grove, United States👥 8 employees💰 Last funded Mar 2025
Sensars is pioneering neuromodulation for diabetic neuropathy with SENSY, the first system to restore natural sensations to the feet, preventing complications like ulcers, amputations, falls, and addressing chronic neuropathic pain. With over25 peer-reviewed publications, successful clinical studies, $3.5M in undiluted grants, and a breakthrough device designation from the FDA, Sensars is advancing its proven technology, moving toward pivotal trials and commercial readiness.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Sensars?
Sensars has 1 investors on record on gritt.io.
When did Sensars last raise funding?
The most recent investment in Sensars recorded on gritt.io was in March 2025.
What industry is Sensars in?
Sensars operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Sensars based?
Sensars is headquartered in West Grove, United States.